Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $44.7600 (-1.65%) ($44.1800 - $45.5800) on Wed. Aug. 19, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.03% (three month average) | RSI | 39 | Latest Price | $44.7600(-1.65%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN declines -2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(46%) XBI(42%) XLV(37%) QQQ(30%) SPY(30%) | Factors Impacting SGEN price | SGEN will decline at least -1.015% in a week (0% probabilities). VIXM(-18%) TLT(-8%) SHY(-5%) IYT(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.015% (StdDev 2.03%) | Hourly BBV | 0 () | Intraday Trend | -0.3% | | | |
|
Resistance Level | $46.42 | 5 Day Moving Average | $45.17(-0.91%) | 10 Day Moving Average | $45.1(-0.75%) | 20 Day Moving Average | $46.42(-3.58%) | To recent high | -13.3% | To recent low | 8.6% | Market Cap | $7.782b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |